Greenleaf Trust’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $765K | Sell |
2,965
-341
| -10% | -$88K | 0.01% | 390 |
|
|
2025
Q1 | $740K | Buy |
3,306
+260
| +9% | +$58.2K | 0.01% | 399 |
|
|
2024
Q4 | $697K | Sell |
3,046
-222
| -7% | -$50.8K | 0.01% | 428 |
|
|
2024
Q3 | $798K | Buy |
3,268
+172
| +6% | +$42K | 0.01% | 392 |
|
|
2024
Q2 | $593K | Buy |
3,096
+81
| +3% | +$15.5K | 0.01% | 433 |
|
|
2024
Q1 | $597K | Buy |
3,015
+39
| +1% | +$7.72K | 0.01% | 428 |
|
|
2023
Q4 | $512K | Buy |
2,976
+1,223
| +70% | +$210K | 0.01% | 455 |
|
|
2023
Q3 | $259K | Sell |
1,753
-632
| -26% | -$93.5K | ﹤0.01% | 628 |
|
|
2023
Q2 | $521K | Sell |
2,385
-169
| -7% | -$36.9K | 0.01% | 442 |
|
|
2023
Q1 | $559K | Buy |
2,554
+108
| +4% | +$23.7K | 0.01% | 413 |
|
|
2022
Q4 | $509K | Sell |
2,446
-83
| -3% | -$17.3K | 0.01% | 441 |
|
|
2022
Q3 | $552K | Buy |
2,529
+226
| +10% | +$49.3K | 0.01% | 372 |
|
|
2022
Q2 | $483K | Buy |
2,303
+53
| +2% | +$11.1K | 0.01% | 401 |
|
|
2022
Q1 | $546K | Buy |
2,250
+218
| +11% | +$52.9K | 0.01% | 389 |
|
|
2021
Q4 | $529K | Buy |
2,032
+59
| +3% | +$15.4K | 0.01% | 405 |
|
|
2021
Q3 | $520K | Buy |
1,973
+145
| +8% | +$38.2K | 0.01% | 378 |
|
|
2021
Q2 | $451K | Sell |
1,828
-118
| -6% | -$29.1K | 0.01% | 425 |
|
|
2021
Q1 | $378K | Buy |
1,946
+345
| +22% | +$67K | 0.01% | 469 |
|
|
2020
Q4 | $340K | Buy |
1,601
+160
| +11% | +$34K | ﹤0.01% | 423 |
|
|
2020
Q3 | $247K | Buy |
1,441
+55
| +4% | +$9.43K | ﹤0.01% | 464 |
|
|
2020
Q2 | $266K | Sell |
1,386
-351
| -20% | -$67.4K | ﹤0.01% | 433 |
|
|
2020
Q1 | $256K | Buy |
+1,737
| New | +$256K | 0.01% | 370 |
|